Pre-clinical experimentation and clinical research
Pre-clinical experimentation and clinical research
Contact
Arronax Nantes > Pre-clinical experimentation and clinical research > Our publications

Our publications

  • Study of radiolabeled hepatotropic peptide derivatives for the diagnosis and treatment of hepatocellular carcinoma
    Nahas H, Brossard C, Vene E, Gouard S, Chérel M, Bourgeois M, Loyer P, Lepareur N, Cammas-Marion S
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, october 5-8 2022

  • Novel Positron Emission Tomography with Opaque Liquid Scintillator Detection Technology
    Hourlier A, Bongrand M, Bourgeois C, Brasse D, Breton D, Briere M, Cabrera A, Chaumat V, Dahmane A, Gazzini R, Giovagnoli D, Haddad F, Hull G, Lanièce P, Lefevre F, Loaiza P, Maalmi J, Mellak Y, merlin T, Mastrippolito R, Marquet C, Ménard L, navas-Nicolas D, Pillot P, Simard L, Stocco D, Verdier MA, Visvikis D, Yermia F
    15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, october 5-8 2022

  • La ligne de faisceau d’Arronax pour les études précliniques
    Koumeir C
    GO of GDR MI2B, Orsay, France, june 13-15 2022

  • Prédiction de survie à partir des images TEP dans le contexte du myélome multiple.
    Morvan L.
    Journée scientifique TransForMed4Students, Nantes (Loire Atlantique), France, July 6 2021

  • Recalage d’images TEP pour le suivi du cancer du sein métastatique.
    Fourcade C.
    Journée scientifique TransForMed4Students, Nantes (Loire Atlantique), France, July 6 2021

  • Local-mean preserving post-processing step for non-negativity enforcement in PET imaging: application to 90Y-PET.
    Millardet M.
    Journée scientifique TransForMed4Students, Nantes (Loire Atlantique), France, July 6 2021

  • Nouveaux biomarqueurs en imagerie du carcinome hépatocellulaire.
    David A.
    Journée scientifique TransForMed4Students, Nantes (Loire Atlantique), France, July 6 2021

  • Développement de l’alphathérapie dans le traitement des tumeurs neuroendocrines différenciées.
    Lugat A.
    Journée scientifique TransForMed4Students, Nantes (Loire Atlantique), France, July 6 2021

  • 64Cu-ATSM as a therapeutic agent in solid tumor? preliminary results of a whole body human dosimetry study OP-0360.
    Varmenot N, Colombié M, Rousseau C, Haddad F, Ferrer L
    EANM’21 34th Annual congress of the European Association of Nuclear Medicine, virtual edition, October 20-23 2021

  • Preclinical study of Targeted Alpha Therapy using 211At-labeled phenylalaline derivative in a syngeneic Multiple Myeloma model OP-0106.
    Gaschet J, Echeynne R, Chouin N, Gazzola S, Guérard F, Gouard S, Marionnaud-Lambot S, Maubert AL, Alliot C, Hofgaard PO, Bogen B, Yan E, Haddad F, Kraeber-Bodéré F, Wheatcroft M, Gestin JF, Chérel M
    EANM’21 34th Annual congress of the European Association of Nuclear Medicine, virtual edition, October 20-23 2021

see more results